PMC:7212965 / 36749-37623
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T79 | 33-38 | Body_part | denotes | Liver | http://purl.org/sig/ont/fma/fma7197 |
T80 | 309-315 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
T81 | 611-616 | Body_part | denotes | liver | http://purl.org/sig/ont/fma/fma7197 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T61 | 33-38 | Body_part | denotes | Liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
T62 | 611-616 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T174 | 58-66 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T175 | 167-175 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T176 | 390-398 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T177 | 679-687 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T289 | 33-38 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | Liver |
T290 | 33-38 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | Liver |
T291 | 185-188 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T292 | 309-315 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T293 | 351-354 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T294 | 463-475 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | Organization |
T295 | 492-493 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T296 | 572-575 | http://purl.obolibrary.org/obo/PR_000001343 | denotes | aim |
T297 | 587-588 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T298 | 611-616 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
T299 | 611-616 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | liver |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T57 | 260-278 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T58 | 280-290 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T59 | 339-350 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
T60 | 745-747 | Chemical | denotes | GI | http://purl.obolibrary.org/obo/CHEBI_73907 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T229 | 0-78 | Sentence | denotes | What Are Common Gastrointestinal/Liver Adverse Effects of COVID-19 Treatments? |
T230 | 79-176 | Sentence | denotes | `There are currently no US Food and Drug Administration–approved routine treatments for COVID-19. |
T231 | 177-399 | Sentence | denotes | The FDA has issued an emergency use authorization for 3 therapies: choloroquine or hydroxychloroquine, remdesivir, and convalescent plasma.82 In China and Japan, favipiravir has been approved for the treatment of COVID-19. |
T232 | 400-733 | Sentence | denotes | Numerous medications are under investigation; the World Health Organization is spearheading a multinational, multicenter trial for the 5 treatments highlighted below.83 We aim to provide a summary of the Gl and liver adverse effects of the most commonly utilized medications for COVID-19 at this time, irrespective of their efficacy. |
T233 | 734-874 | Sentence | denotes | Medication GI-related adverse events are summarized in Supplementary Tables 1 and 2 (direct evidence sources and indirect evidence sources). |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
924 | 16-32 | Gene | denotes | Gastrointestinal | Gene:2770 |
925 | 58-66 | Disease | denotes | COVID-19 | MESH:C000657245 |
934 | 745-747 | Gene | denotes | GI | Gene:2770 |
935 | 244-256 | Chemical | denotes | choloroquine | |
936 | 260-278 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
937 | 280-290 | Chemical | denotes | remdesivir | MESH:C000606551 |
938 | 339-350 | Chemical | denotes | favipiravir | MESH:C462182 |
939 | 167-175 | Disease | denotes | COVID-19 | MESH:C000657245 |
940 | 390-398 | Disease | denotes | COVID-19 | MESH:C000657245 |
941 | 679-687 | Disease | denotes | COVID-19 | MESH:C000657245 |